I was born and raised in India. On the day I was born, I am told I got my first jab, a vaccine called BCG (bacille Calmette-Guerin). Kids born in India today still get this vaccine. This century-old ...
ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial ...
Bob Field was set to kick off his second course of BCG — a potent immunotherapy that treats his fast-growing bladder cancer. Instead, the New York City banking executive got a call from his ...
Please provide your email address to receive an email when new articles are posted on . Bacillus Calmette-Guérin, or BCG, is highly effective at treating and preventing recurrence of early-stage ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
A phase 3 trial supports durvalumab added to BCG induction and maintenance therapy as a potential new treatment for BCG-naïve, high-risk NMIBC. Adding durvalumab to Bacillus-Calmette-Guerin (BCG) ...
BOSTON, Jan. 6, 2026 /PRNewswire/ -- In the second half of 2025, Boston Consulting Group (BCG) was recognized as a Leader in six key analyst reports: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback